Crossmark

Treatment of diabetic foot ulcers in a frail population with severe co-morbidities using at-home photobiomodulation laser therapy: a double-blind, randomized, sham-controlled pilot clinical study

Crossref DOI link: https://doi.org/10.1007/s10103-021-03335-9

Published Online: 2021-05-29

Published Print: 2022-03

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Haze, Amir https://orcid.org/0000-0002-8749-3009
Gavish, Lilach https://orcid.org/0000-0003-0392-8958
Elishoov, Ofer https://orcid.org/0000-0003-2237-900X
Shorka, Dorit

Tsohar, Tamir

Gellman, Yechiel N. https://orcid.org/0000-0003-4913-8812
Liebergall, Meir https://orcid.org/0000-0002-2470-2192
License Information

Text and Data Mining valid from 2021-05-29

Version of Record valid from 2021-05-29
More Information

Article History

Received: 1 March 2021

Accepted: 3 May 2021

First Online: 29 May 2021

Declarations

:

: This clinical trial (ClinicalTrials.gov: NCT01493895) was approved by the clinical trial ethical review board of The Hadassah Medical Organization (0122–11-HMO) prior to recruitment.

: All patients provided written informed consent before entering the study.

: Figure contains feet from 2 patients. The pictures were taken during 2014. Both patients are deceased; one died in 2015 and the other in 2018. The text was anonymized by omitting the exact age and gender from the legend. There is no additional identifiable data in the photos.

: The individual measurements collected in this study and details of diabetes status and care (according to Jeffcoat et al. []) are reported in Supplementary Tables and .

: LG is paid as a consultant by the manufacturer of the device to give recommendations for treatment protocols. This was not relevant in this study. All other authors declare no competing interests.

Document is current

Any future updates will be listed below